Summary of equity attributable to Novartis AG shareholders (Tables)

6 Months Ended

Jun. 30, 2025

Disclosure of equity [abstract]

Schedule disclosing information related treasury shares movements

				Number of outstanding shares (in millions)				Equity attributable to Novartis AG shareholders



		Note		2025		2024		H1 2025 USD millions		H1 2024 USD millions

Balance at beginning of year				1 975.1		2 044.0		44 046		46 667

Shares acquired to be canceled				-48.8		-26.7		-5 350		-2 698

Other share purchases				-1.6		-1.1		-159		-115

Equity-based compensation plans and employee transactions				11.1		8.3		557		517

Taxes on treasury share transactions								-33		8

Dividends		4.1						-7 818		-7 624

Net income of the period attributable to shareholders of Novartis AG								7 647		5 934

Other comprehensive income attributable to shareholders of Novartis AG								3 027		-1 054

Changes in non-controlling interests								1		-28

Other movements		4.3		0.1		0.1		67		126

Balance at June 30				1 935.9		2 024.6		41 985		41 733